Staurosporine (a kinase inhibitor) appears to induce an anti-tumor response in the cervical tumor microenvironment, and inhibits cancer progression and metastases through suppression of MMP-1 and MMP-2 [25]. This evidence concerns the gene MMP1 and cancer.